The etiology of inflammatory bowel disease has not been elucidate

The etiology of inflammatory bowel disease has not been elucidated, but is thought to be multifactorial with both environmental and genetic influences. A large body of research has been conducted to elucidate the etiology of inflammatory bowel disease. This article reviews this literature, emphasizing the studies of breastfeeding and the studies of genetic factors, particularly NOD2 polymorphisms. (C) 2009 The WJG Press and Baishideng. All rights reserved.”
“Objective\n\nPrevention of postpartum

haemorrhage is essential in the pursuit of improved health care for women. However, limited literature is available for comparing the use of oxytocin agonist carbetocin with syntometrine in women undergoing vaginal deliveries. We aimed to compare intramuscular carbetocin ABT-737 ic50 with intramuscular syntometrine for the routine prevention of postpartum haemorrhage in women who deliver vaginally.\n\nDesign\n\nProspective double-blind randomised controlled trial.\n\nSetting\n\nTertiary referral centre.\n\nPopulation\n\nPregnant

women with no contraindication for vaginal delivery recruited from January 2005 to April 2008.\n\nMethods\n\nParticipants were randomised to receive either syntometrine or carbetocin during the third stage of labour.\n\nMain outcome measures\n\nPrimary outcome measure was postpartum haemorrhage requiring additional uterotonics. GSK126 solubility dmso Secondary outcome measures were the incidence of postpartum haemorrhage (>= 500 ml), severe postpartum haemorrhage (>= 1000 ml) and adverse effects profile.\n\nResults\n\nWomen in the carbetocin group (13.5%) and in the syntometrine group (16.8%) had postpartum haemorrhage requiring additional Blebbistatin cell line uterotonics (P = 0.384). 1.6% of women in each group had postpartum haemorrhage (P = 1.0) and the estimated blood loss during the third stage of labour was similar between the two groups (P = 0.294). Women who had syntometrine were four times more likely

to experience nausea (RR = 4.2; 95% CI 2.2-7.8) and vomiting (RR = 4.3; 95% CI 1.9-9.5) compared with women who had carbetocin. Tremor, sweating, retching and uterine pain were also more likely in the syntometrine group compared with the carbetocin group (P < 0.05).\n\nConclusions\n\nCarbetocin has an efficacy similar to syntometrine for prevention of postpartum haemorrhage, but is associated with less adverse effects.”
“Indoor hockey is a highly competitive international sport, yet no research to date has investigated the key actions within this sport. As with outdoor field hockey, penalty corners represent one of the most likely situations in which goals can be scored. All 36 matches of the round-robin phase of the 20102011 England Hockey League Women’s Premier Division Super Sixes’ competition were analysed with the purpose of establishing which factors can predict the scoring of a goal using binary logistic regression analysis. Seventy-two (22.

Comments are closed.